Search Results - Maron, Steven
- Showing 1 - 20 results of 24
- Go to Next Page
-
1
-
2
-
3
-
4
Targeting EGFR in Esophagogastric Cancer by Maron, Steven B., Xu, James, Janjigian, Yelena Y.
Published 2020Text -
5
Lineage specific recombination and positive selection in coding and intragenic regions contributed to evolution of the main Listeria monocytogenes virulence gene cluster by Orsi, Renato H., Maron, Steven B., Nightingale, Kendra K., Jerome, Morganne, Tabor, Helen, Wiedmann, Martin
Published 2008Text -
6
Initial Report of Second‐Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi‐Institutional Retrospective Analysis by Klempner, Samuel J., Maron, Steven B., Chase, Leah, Lomnicki, Samantha, Wainberg, Zev A., Catenacci, Daniel V.T.
Published 2018Text -
7
Obtaining Knowledge in Pathology Reports Through a Natural Language Processing Approach With Classification, Named-Entity Recognition, and Relation-Extraction Heuristics by Oliwa, Tomasz, Maron, Steven B., Chase, Leah M., Lomnicki, Samantha, Catenacci, Daniel V.T., Furner, Brian, Volchenboum, Samuel L.
Published 2019Text -
8
The effect of pre-existing mental health comorbidities on the stage at diagnosis and timeliness of care of solid tumor malignances in a Veterans Affairs (VA) medical center by Wadia, Roxanne J, Yao, Xiaopan, Deng, Yanhong, Li, Jia, Maron, Steven, Connery, Donna, Gunduz-Bruce, Handan, Rose, Michal G
Published 2015Text -
9
-
10
Validation of the Memorial Sloan Kettering Gastric Cancer Post-Resection Survival Nomogram: Does It Stand the Test of Time? by Nakauchi, Masaya, Court, Colin M, Tang, Laura H, Gönen, Mithat, Janjigian, Yelena Y, Maron, Steven B, Molena, Daniela, Coit, Daniel G, Brennan, Murray F, Strong, Vivian E
Published 2022Text -
11
Outcomes of neoadjuvant chemotherapy in clinical stage II/III gastric cancer patients: analysis of timing and site of recurrence by Nakauchi, Masaya, Vos, Elvira, Tang, Laura H., Gonen, Mithat, Janjigian, Yelena Y., Ku, Geoffrey Y., Ilson, David H., Maron, Steven B., Yoon, Sam S., Brennan, Murray F., Coit, Daniel G., Strong, Vivian E.
Published 2021Text -
12
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape by Klempner, Samuel J., Madison, Russell, Pujara, Vivek, Ross, Jeffrey S., Miller, Vincent A., Ali, Siraj M., Schrock, Alexa B., Kim, Seung Tae, Maron, Steven B., Dayyani, Farshid, Catenacci, Daniel V.T., Lee, Jeeyun, Chao, Joseph
Published 2019Text -
13
Association of Obesity With Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection by Nakauchi, Masaya, Vos, Elvira L., Tang, Laura H., Gonen, Mithat, Janjigian, Yelena Y., Ku, Geoffrey Y., Ilson, David H., Maron, Steven B., Yoon, Sam S., Brennan, Murray F., Coit, Daniel G., Strong, Vivian E.
Published 2021Text -
14
Survival Following Trimodality Therapy in Patients with Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter? by Sihag, Smita, Nobel, Tamar, Hsu, Meier, De La Torre, Sergio, Tan, Kay See, Janjigian, Yelena Y., Ku, Geoffrey Y., Tang, Laura H., Wu, Abraham J., Maron, Steven B., Bains, Manjit S., Jones, David R., Molena, Daniela
Published 2022Text -
15
Circulating tumor DNA sequencing of gastroesophageal adenocarcinoma. by Maron, Steven B., Chase, Leah M., Lomnicki, Samantha, Kochanny, Sara, Moore, Kelly L., Joshi, Smita S., Landron, Stacie, Johnson, Julie, Kiedrowski, Lesli A., Nagy, Rebecca J., Lanman, Richard B., Kim, Seung Tae, Lee, Jeeyun, Catenacci, Daniel V.T.
Published 2019Text -
16
Targeted therapies for targeted populations: Anti-EGFR treatment for EGFR amplified gastroesophageal adenocarcinoma by Maron, Steven B., Alpert, Lindsay, Kwak, Heewon A., Lomnicki, Samantha, Chase, Leah, Xu, David, O’Day, Emily, Nagy, Rebecca J., Lanman, Richard B., Cecchi, Fabiola, Hembrough, Todd, Schrock, Alexa, Hart, John, Xiao, Shu-Yuan, Setia, Namrata, Catenacci, Daniel V.T.
Published 2018Text -
17
Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts by Moy, Ryan H., Walch, Henry S., Mattar, Marissa, Chatila, Walid K., Molena, Daniela, Strong, Vivian E., Tang, Laura H., Maron, Steven B., Coit, Daniel G., Jones, David R., Hechtman, Jaclyn F., Solit, David B., Schultz, Nikolaus, de Stanchina, Elisa, Janjigian, Yelena Y.
Published 2022Text -
18
Induction FOLFOX and PET-directed chemoradiation for locally advanced esophageal adenocarcinoma by Carr, Rebecca A., Hsu, Meier, Harrington, Caitlin A., Tan, Kay See, Bains, Manjit S., Bott, Matthew J., Ilson, David H., Isbell, James M., Janjigian, Yelena Y., Maron, Steven B., Park, Bernard J., Rusch, Valerie W., Sihag, Smita, Wu, Abraham J., Jones, David R., Ku, Geoffrey Y., Molena, Daniela
Published 2023Text -
19
The Role of the TP53 Pathway in Predicting Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma by Sihag, Smita, Nussenzweig, Samuel C., Walch, Henry S., Hsu, Meier, Tan, Kay See, De La Torre, Sergio, Janjigian, Yelena Y., Maron, Steven B., Ku, Geoffrey Y., Tang, Laura H., Shah, Pari M., Wu, Abraham, Jones, David R., Solit, David B., Schultz, Nikolaus, Ganesh, Karuna, Berger, Michael F., Molena, Daniela
Published 2022Text -
20
Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways by Sihag, Smita, Nussenzweig, Samuel C., Walch, Henry S., Hsu, Meier, See Tan, Kay, Sanchez Vega, Francisco, Chatila, Walid K., De La Torre, Sergio, Patel, Assem, Janjigian, Yelena Y., Maron, Steven, Ku, Geoffrey Y., Tang, Laura H., Hechtman, Jaclyn, Shah, Pari M., Wu, Abraham, Jones, David R., Molena, Daniela, Solit, David B., Schultz, Nikolaus, Berger, Michael F.
Published 2021Text